Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2000
07/26/2000EP0880698A4 Visual inspection system for leather hide
07/26/2000EP0870063B1 Fluorescence detection assay for homogeneous pcr hybridization systems
07/26/2000EP0828752A4 Chitotriosidase
07/26/2000EP0793830A4 Improved accuracy in cell mitosis analysis
07/26/2000EP0786084A4 Method for screening compositions
07/26/2000EP0755458A4 Electrogenerated chemiluminescence labels for analysis and/or referencing
07/26/2000EP0629293B1 Assay for adrenal autoantibodies
07/26/2000CN2389384Y Temp. control intrument for biologial probe diagnostic chip
07/26/2000CN1261407A Method based on use of bacteriophages for detection hiological molecules in biological samples
07/26/2000CN1261403A Surface exposed proteins from chlamydia pneumoniae
07/26/2000CN1054917C Micro photo lysis-analysis process to measure cell characteristics
07/26/2000CN1054878C Use of azo dyes for marking hydrocarbons and novel azo dyes
07/25/2000US6094265 Calibrator for non-destructive transmission optical measuring apparatus
07/25/2000US6093869 Sensor that detects an input, an actuator to perform a responsive function upon input, and feedback control loop in which the actuator performs the responsive function upon the input when the sensor detects the input; diapers
07/25/2000US6093808 IκBEGFP constructs, cell lines and methods of use
07/25/2000US6093803 Method of producing aminoterminal propeptide of type 1 procollagen
07/25/2000US6093801 Recombinant analogs of bactericidal/permeability increasing protein
07/25/2000US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells
07/25/2000US6093693 B cell activation
07/25/2000US6093681 Composition and method for treating plants with exogenous chemicals
07/25/2000US6093680 Composition and method for treating plants with exogenous chemicals
07/25/2000US6093559 Producing low binding hydrophobic surfaces by treating with a low HLB number non-ionic surfactant
07/25/2000US6093558 Applying to a substrate an adhesive comprising a nonproteinaceous polymer of monomeric units comprising an aromatic moiety having hydroxyl group(s); contacting a bioactive protein (such as cell) with substrate to immobilize
07/25/2000US6093552 Kit comprising a conjugate of a pure cloned chitinase enzyme and a label selected from a radiactive material, fluorescent material, a dye, and an enzyme, the conjugate binds to yeast chitin but not cellulose or glucan; and filter to retain cell
07/25/2000US6093551 Process and device for in vitro diagnosis of allergic disorders
07/25/2000US6093550 Unique associated Kaposi's sarcoma virus sequences and uses thereof
07/25/2000US6093549 Identifying candidate therapeutic agents which interfere with huntingtin associated protein-1(hap1) and huntingtin binding by contacting these proteins and a compound, determining if the compound diminishes the two proteins from binding
07/25/2000US6093548 Incubating a vertebrate sample iwth an mn protein, mn fusion protein, or mn polypeptide, where mn is a gene associated with tumorigenicity; detecting or quantitating binding of the mn protein to antibodies in the sample; assay test kit
07/25/2000US6093546 Process for preparing test elements
07/25/2000US6093543 Isolating and purifying dna synthesome from a cell or tissue sample, measuring test complex mutation frequency and comparing to control complex mutation frequency as indicator of cancer/tumors
07/25/2000US6093537 Detecting target sequence in sample by mixing with pair of nucleotide sequences, hybridizing, attaching nucleotide sequences together, adding nucleotide sequence specific binding proteins, and detecting binding
07/25/2000US6093536 Wood's anomaly assay technique and kit
07/25/2000US6093534 Monoclonal antibody specifically recognizing adeno-associated virus cap protein
07/25/2000US6093533 Screening for modulators of bone resorption by culturing tartarate resistant acid phosphatase positive prefusion osteoclasts, osteoblasts, vitamin d3 or derivative and compound on a bone slice and measuring resorption
07/25/2000US6093324 Purification of immunoglobulins
07/25/2000US6093308 Sensors for detecting analytes in fluids
07/25/2000US6093156 Method and apparatus for obtaining blood for diagnostic tests
07/25/2000US6092427 Method of testing a bond interface
07/25/2000CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
07/25/2000CA2076754C Oral collection for immunoassay
07/25/2000CA2015377C Autoantibodies which enhance the rate of a chemical reaction
07/20/2000WO2000042438A1 Optical-chemical sensor for detecting chloride
07/20/2000WO2000042437A1 Methods for differentiating and monitoring parathyroid and bone status related diseases
07/20/2000WO2000042436A1 Immunoassays to detect diseases or disease susceptibility traits
07/20/2000WO2000042435A1 Methods for detecting an analyte of interest using tyramide coating technology
07/20/2000WO2000042434A1 Method and device for determining an analyte
07/20/2000WO2000042433A1 Method and biosensor for detecting antigen
07/20/2000WO2000042432A1 Purification process using magnetic particles
07/20/2000WO2000042431A1 Methods and assay kits for detecting mononuclear cell phenotype
07/20/2000WO2000042430A1 Lateral flow test strip
07/20/2000WO2000042428A1 Methods of determining an increased risk of a woman carrying a downs syndrome
07/20/2000WO2000042427A1 Detection of base contaminants in gas samples
07/20/2000WO2000042424A1 Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels
07/20/2000WO2000042422A1 Disposable test strips with integrated reagent/blood separation layer
07/20/2000WO2000042421A1 Method for screening for type b trichothecene mycotoxins
07/20/2000WO2000042302A1 Method and arrangement for purifying an exhaust gas stream of a spark ignition engine flowing in an exhaust gas line
07/20/2000WO2000042220A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
07/20/2000WO2000042217A2 Method for electrochemically detecting nucleic acid-oligomer hybridisation events
07/20/2000WO2000042216A2 Genetic predisposition to abnormal calcification conditions
07/20/2000WO2000042213A1 A novel method for designing protein kinase inhibitors
07/20/2000WO2000042212A1 Optimized high-throughput analytical system
07/20/2000WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
07/20/2000WO2000042208A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
07/20/2000WO2000042205A2 Herbicide target gene and methods
07/20/2000WO2000042202A1 A method for introducing substances into cells, and use of said method
07/20/2000WO2000042201A2 Human peptidases
07/20/2000WO2000042192A1 Neisseria meningitidis polypeptide basb052
07/20/2000WO2000042191A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
07/20/2000WO2000042188A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
07/20/2000WO2000042181A1 Minor histocompatibility antigens and their use in diagnosis and treatment of tumors
07/20/2000WO2000042172A2 Human homologues of proteins regulated by circadian rhythms
07/20/2000WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor
07/20/2000WO2000042166A2 Methods and compositions for monitoring cellular processing of epitope-tagged beta-amyloid precursor protein
07/20/2000WO2000042165A2 Bone marrow-specific protein
07/20/2000WO2000042074A1 Anti-ccr4 antibodies and methods of use therefor
07/20/2000WO2000042072A2 Polypeptide variants with altered effector function
07/20/2000WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response
07/20/2000WO2000042069A1 Bone stimulating factor
07/20/2000WO2000042064A1 Peptides for inhibiting hpv e6 proteins
07/20/2000WO2000042048A1 A reagent system and method for increasing the luminescence of lanthanide(iii) macrocyclic complexes
07/20/2000WO2000042042A2 High affinity inhibitors for target validation and uses thereof
07/20/2000WO2000041723A1 Molecularly imprinted microspheres prepared using precipitation polymerisation
07/20/2000WO2000041696A1 Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
07/20/2000WO2000041623A1 A breath test for the detection of various diseases
07/20/2000WO2000041610A2 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease
07/20/2000WO2000041561A1 Bacterial cell component-unresponsive model mouse
07/20/2000WO2000041549A2 Binary probe and clamp composition and methods for target hybridization detection
07/20/2000WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000WO2000041516A2 Reagents and methods useful for detecting diseases of the breast
07/20/2000WO2000041497A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
07/20/2000WO2000041472A2 Binding partners for 5-ht5-receptors for the treatment of migraine
07/20/2000WO2000026230A8 Low allergenic protein variants
07/20/2000WO2000020586A3 Renal cancer associated antigens and uses therefor
07/20/2000WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
07/20/2000WO2000018949A3 Delivery of phosphoinositide polyphosphates into cells
07/20/2000WO2000017235A3 Cytokine receptor zalpha11
07/20/2000WO2000013590A3 System and method for radiographic imaging of tissue
07/20/2000WO2000013017A3 Method and device for producing and/or analyzing biochemical reaction supporting materials
07/20/2000WO2000012140A8 Method for labeling biopolymers using isotopes
07/20/2000WO2000011446A3 Signal generating oligonucleotide-based biosensor